Share 0
Share 0
Post 0

Early cranial radiotherapy may improve outcomes for patients with EGFR-mutant NSCLC and limited brain metastases

Thursday, September 17th, 2026

Early cranial stereotactic radiotherapy (SRT) administered with first-line osimertinib was associated with improved intracranial control and survival outcomes in patients with EGFR-mutant non-small cell lung cancer (NSCLC) and limited brain metastases, according to research presented at the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC).

WE WANT YOU!

are you a developer?

  • Proven International Track Record
  • Vertically Integrated Federal Funds
  • Vertically Integrated Tax Credits
  • Vertically Integrated Investors
  • Vertically Integrated Lenders
  • Vertically Integrated Contractors
 List your project

Report

Contains abusive or threatening content.
There has been a breach of confidentiality.
There has been a breach of contract.
There has been a breach of fiduciary within a partnership.
Contains mature, sensitive, or otherwise inappropriate content.
Contains misleading or false information with perceived intent.
Harassment or otherwise unwanted, unprofessional, or excessive communication or attempted communication.
Contains spam, potential malware, or otherwise not generally professional content.

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .